Ireland Health News API

{
    "totalArticles": 206868,
    "articles": [
        {
            "id": "3bcd5fa9406d86e3dbd83ff093ec311b",
            "title": "Poll reveals gaps in brain health awareness among older adults",
            "description": "Nearly all Michiganders age 50 and over say it's very important to keep their brains healthy as they grow older, a new poll finds.",
            "content": "Nearly all Michiganders age 50 and over say it's very important to keep their brains healthy as they grow older, a new poll finds.\nBut less than half (47%) of middle-aged and older Michiganders know that everyday actions can be very important for red... [6205 chars]",
            "url": "https://www.news-medical.net/news/20260618/Poll-reveals-gaps-in-brain-health-awareness-among-older-adults.aspx",
            "image": "https://www.news-medical.net/image-handler/picture/2018/7/shutterstock_1028141632_649cad8889c647fc8d0bd83bf7503e08-620x480.jpg",
            "publishedAt": "2026-06-19T03:04:00Z",
            "lang": "en",
            "source": {
                "id": "f2ca7a45d20357cb42858868cb4a4946",
                "name": "News-Medical",
                "url": "https://www.news-medical.net"
            }
        },
        {
            "id": "2d9e35f7827d134165841cdfb865c6ad",
            "title": "Scientists May Have Found What Really Triggers Alzheimer’s Disease",
            "description": "Scientists may have uncovered a hidden trigger behind Alzheimer’s disease. Instead of plaques being the root cause, amyloid beta appears to interfere with tau, a protein that helps keep neurons functioning properly. This disruption could set off the damage that eventually leads to the disease’s most recognizable brain changes.",
            "content": "For years, Alzheimer's research has largely centered on amyloid beta (a-beta), a protein that forms clumps in the brains of people with the disease. The idea gained support because inherited mutations that increase a-beta levels can cause early onset... [4235 chars]",
            "url": "http://www.sciencedaily.com/releases/2026/06/260617032209.htm",
            "image": "https://www.sciencedaily.com/images/1920/neuron-damage-brain-cell-inflammation.webp",
            "publishedAt": "2026-06-19T02:51:48Z",
            "lang": "en",
            "source": {
                "id": "8400452cd3ae520c3deec87e0653d197",
                "name": "ScienceDaily",
                "url": "http://www.sciencedaily.com"
            }
        },
        {
            "id": "51d9e5c463a7d107e3af70b920338db3",
            "title": "Characterization of IgG N-glycan patterns in COVID-19, sepsis and healthy subjects",
            "description": "Patients with severe infectious diseases may require admission to intensive care units (ICUs) when the infection progresses to severe forms, as observed in sepsis or, more recently, in COVID-19. Despite advances in critical care, the risk of progression toward severe or fatal outcomes remains difficult to predict, highlighting the need for reliable prognostic biomarkers. Immunoglobulin G (IgG) N-glycosylation has emerged as a key modulator of immune responses and may represent a valuable biomarker for assessing disease severity. In this study, we investigated the IgG N-glycans profiles to evaluate their potential association with clinical outcome in critically ill patients with sepsis or COVID-19. Serum IgG N-glycans were characterized using online hydrophilic interaction liquid chromatography (HILIC) solid-phase extraction, followed by HILIC separation and fluorescence and mass spectrometry detection. The study cohort included healthy controls, ICU patients with sepsis or severe COVID-19, the latter being further stratified according to survival outcome. Distinct IgG N-glycosylation patterns and relative abundances of specific N-glycan structures in serum were associated with disease etiology (sepsis versus COVID-19) as well as with patient outcomes for COVID-19 group. These findings suggest that IgG glycosylation profiling may provide a promising approach for stratifying ICU patients according to their risk of developing severe or fatal diseases.",
            "content": "Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give... [797 chars]",
            "url": "https://www.nature.com/articles/s41598-026-57666-0?error=cookies_not_supported&code=b77b8acf-a380-441c-aef1-40c4c274b648",
            "image": "https://www.nature.com/static/images/favicons/nature/favicon-48x48-b52890008c.png",
            "publishedAt": "2026-06-19T02:24:22Z",
            "lang": "en",
            "source": {
                "id": "7abf0df285fbe93cdccffcc7c4088737",
                "name": "Nature",
                "url": "https://www.nature.com"
            }
        }
    ]
}